#5e2d92_SMALL_Nov-Dec 2024 DRA Journal Cover

From myth-busting photobiomodulation therapy to showcasing advanced aesthetic cases, this issue delivers practical insights for modern dental practice. Explore evidence-based techniques in implant and veneer rehabilitation, essential guidance on monkeypox protocols, and strategies for enhanced patient communication.

>> FlipBook Version (Available in English)

>> Mobile-Friendly Version (Available in Multiple Languages)

Click here to access Asia's first Open-Access, Multi-Language Dental Publication

Keystone Dental Unveils GENESIS ACTIVE™ Implant System

Keystone Dental Holdings has officially launched the GENESIS ACTIVE™ Implant System, a surgical solution poised to reshape how dental professionals approach implant placement and restoration. 

Melker Nilsson, CEO of Keystone Dental, expressed that the GENESIS ACTIVE Implant System represents a groundbreaking innovation in dental implantology, setting a new standard for implant procedures.

According to the press release, the GENESIS ACTIVE Implant System is a result of over a decade of research and development, offering a comprehensive, innovative restorative portfolio. 

With one connection, three emergence profiles, and multiple restorative platforms, the system aims to simplify the restorative protocol while providing aesthetic restorations that align with natural tooth contours.

Read: Keystone Dental Launches Nexus Connect: AI-Enabled Chairside Implant Scan Analysis

Innovative Features of GENESIS ACTIVE Implant System

  • AnaTite™ – Emulating Natural Soft Tissue: Featuring AnaTite™, a cutting-edge gradual pink anodization process on the coronal aspect, the system replicates the hue of natural soft tissue, enhancing the aesthetic aspect of dental restorations.
  • BioSpark™ – Mimicking Natural Bone: The BioSpark™ surface treatment covers the implant body, mimicking natural bone and promoting bone growth and fast osseointegration. This feature makes the GENESIS ACTIVE Implant System suitable for immediate load protocols.
  • Digital Guidance Sleeve (DGS): The Digital Guidance Sleeve allows guided placement by engaging the handpiece, eliminating the need for drill guide keys. It facilitates an increased entry angle, particularly useful in limited posterior interarch spaces.
  • GENESIS ACTIVE Conical Implant Connection: The conical implant connection ensures a secure implant-to-abutment interface, providing both a bacterial barrier and high mechanical stability.
  • Multi-Unit Abutments Solutions: The system includes a line of pink premium abutments with concave profiles designed to reduce the need for bone profiling. It offers various digital Multi-Unit abutment prosthetics, including an ANGLEBase® Abutment with angle correction capabilities.
  • ELLIPTIBase® Abutment: Designed for areas with limited interdental space, the ELLIPTIBase® Abutment allows up to 20° angle correction for screw-retained solutions.
  • SelectGrip®: Introducing SelectGrip®, an innovative abutment surface that improves restorative adhesion to the final prosthetic, completing the diverse range of restorative innovations.
Read: CONELOG® Implant System: High-Precision Solution for Implant Dentistry

Keystone Dental Group’s Commitment

Keystone Dental Group, headquartered in Irvine, California, aims to provide end-to-end tooth replacement solutions globally. With a comprehensive portfolio, including GENESIS ACTIVE, Molaris™, and Prima Plus™ implant systems, the company focuses on advancing dental care through innovation.

In August 2023, Keystone Dental announced a definitive Business Combination Agreement with Check-Cap Ltd. The agreement aims to create a public company focused on advancing commercial execution and market development of Keystone Dental’s comprehensive portfolio. Upon completion, the combined company will trade on the NASDAQ under the symbol “KSD,” with Melker Nilsson leading the executive team.

Check-Cap, a clinical stage medical diagnostics company, is dedicated to redefining colorectal cancer screening through the introduction of C-Scan®, a screening test designed to detect polyps before they transform into colorectal cancer. C-Scan is currently an investigational device not available for sale in the United States.

Read: Implant Direct Launches the Simply Iconic Implant System

The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.

Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.

The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.

Leave a Reply

Your email address will not be published. Required fields are marked *